Accreditation and CME

How to claim CME from the 2018 South Beach Symposium

If you attended the 2018 South Beach Symposium on March 1-4 and need to claim CME please visit the claim CME website here. You must use the email address you used when registering for the conference to log in and claim CME. If you have issues logging into the website, please contact the SBS staff at

This activity is jointly provided by Global Education Group and South Beach Symposium.

This activity is supported by educational grants from Allergan, Celgene Corporation, Galderma Laboratories, L.P., Pfizer, Fougera Pharmaceuticals Inc., Genzyme Corporation and in-kind donations from Allergan, Galderma Laboratories, L.P.

Target Audience

The educational design of this activity addresses the needs of Nurses, Physician Assistants, Physicians involved in the treatment of patients with dermatology concerns.

Statement of Need/Program Overview

The South Beach Symposium is a four-day educational event delivering content on the newest therapies, technologies, procedures, and practice guidelines for physicians and practitioners in the field of clinical and aesthetic dermatology.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Describe individualized treatment regimens for patients with acne based on evidence-based guidelines
  • Identify recent advances in the treatment of actinic keratosis that have high levels of patients’ satisfaction, decreased treatment duration, and fewer side-effects
  • List the appropriate filler agent to target specific patient characteristics in order to treat different areas of the face and targeted planar depths
  • Compare the efficacy and safety of agents, devices, and techniques currently available in aesthetic dermatology
  • Discuss individualized treatment plans for pediatric and adult patients with moderate-to-severe AD based on current guideline recommendations for AD, the safety and efficacy of new and emerging treatment options, comorbidities, and patient quality of life
  • Identify strategies to improve adherence to AD treatment strategies and assess the effects of treatment on patient QOL
  • Compare evidence-based treatment regimens for chronic idiopathic urticaria
  • Evaluate current and emerging malignant melanoma therapies according to mechanism of action, clinical safety efficacy, and recommended usage
  • Describe the mechanisms of action and efficacy data on new and emerging treatments for onychomycosis
  • Review appropriate therapies for psoriasis in children based on disease severity and available evidence
  • Identify recent advances in pediatric atopic dermatitis knowledge and treatment
  • Compare appropriate therapies for treatment of acne in children from infants to teenagers, based on recent guidelines and available evidence
  • Discuss recent updates in pediatric dermatology including research, advances and therapies
  • Identify practice management tools, business strategies, and compliance issues for successfully maintaining and growing a medical practice
  • Evaluate treatment strategies for moderate-to-severe psoriasis based on an understanding of psoriasis as a systemic immune-mediated disease
  • List appropriate treatment strategies for patients with rosacea based on individualized patient care
  • Explain individualized treatment regimens for patients with wounds, taking into consideration evidence-based guidelines, wound severity and type, the efficacy of combination therapies, patient age, and patient skin type

Program Agenda

The program agenda can be viewed here:

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and The South Beach Symposium. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 29 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 29 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or

Instructions to Receive Credit

An email will be sent following the conclusion of this activity and it will include the online evaluation form and post-test. Both the online evaluation and post-test are required to receive continuing credit.

Fee Information& Refund/Cancellation Policy

SBS will offer a 100% refund within 72 hours from time of purchase less applicable credit card processing fee. After 72 hours refunds will be less 50%. All refunds must be made in writing and post marked or tax stamped no later than 90 days before the event. No refund will be made if the request is made within 90 days of the educational event. Refunds will not be issued to non-show registrants. Substitutions are always welcome in lieu of cancellation for a $100.00 transit fee. No transfers to alternate events will be made if the request is submitted within 90 days of the original event.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Glynis R. Ablon, MD, FAAD
Nothing to Disclose

Shino Bay Aguilera, DO
Consultant: Allergan, Galderma, Cynosure, Skinceuticals; Grant/Research Support: Merz, Solta; Speaker's Bureau: Allergan, Galderma, Cynosure, Merz, Skinceuticals; Stock Shareholder: Solta

Benjamin Ascher, MD
Nothing to Disclose

Laura Auerbach, PA-C
Nothing to Disclose

Judith Avinoa, PA-C
Nothing to Disclose

Brian Berman, MD, PhD
Consultant: LEO, Sensus, DUSA/SUN, Dermira, Novartis, Onset, Galderma, Ferndale, Berg, Valeant, Biofrontera, Bayer, Clark, Medimetrix, Pulse, Miragen, Realm, Sirnaomics, Castle, Novan, Celumigen, Aiviva, Exeltis; Grant/Research Support: LEO, Exeltis, Biofrontera; Speaker's Bureau: EO, Halscion, Sensus, DUSA,, Novartis, Galderma, Genentech, Ferndale, Biofrontera, Exeltis; Stock Shareholder: Dermira, Berg, TopMD, Celumigen

Diane S. Berson, MD
Consultant: Galderma, Valeant, Sunbelt, D&G Sienna, La Roche, Aetoris, Allergan

Neal Bhatia, MD
Consultant: Actavis, Allergan, Anacor, Aqua, Bayer, Biofrontera, BiopharmX, Dermira, Dusa, Exeltis, Ferndale, Foamix, Galderma, Intraderm, ISDIN, LaRoche-Posay, Leo, Novan, Novartis, PharmaDerm, Promius, Regeneron, Sanofi, SunPharma, and Valeant; Grant/Research Support: Actavis, Allergan, Anacor, Aqua, Bayer, Biofrontera, BiopharmX, Dermira, Dusa, Exeltis, Ferndale, Foamix, Galderma, Intraderm, ISDIN, LaRoche-Posay, Leo, Novan, Novartis, PharmaDerm, Promius, Regeneron, Sanofi, SunPharma, and Valeant

Kelly Byard, PA-C
Nothing to Disclose

Suneel Chilukuri, MD, FAAD
Honoraria: Aclaris, Aerolase, Allergan, BTL, Cynosure, Galderma, Invasix, PCA Skin, Skin Medica; Speaker's Bureau: Allergan, BTL, Cynosure, Galderma, Invasix, PCA Skin, Skin Medica

Clay Cockerell, MD
Nothing to Disclose

David E. Cohen, MD, MPH
Consultant: Ferndale, Medimetriks, FIDE; Stock Shareholder: Demira, Medimetricks

Joel L. Cohen, MD
Allergan: Consultant, Honoraria; Merz: Clinical Investigator, Consultant/Honoraria; Galderma: Consultant/Honoraria; LEO: Clinical Investigator; Sciton: Consultant/Honoraria; CROMA: Clinical Investigator; ALMA: Clinical Investigator; Lutronic: Consultant; Neothetics: Clinical Investigator; Revance: Clinical Investigator; Brickell Biotech: Clincal Investigat

Doris J. Day, MD
Honoraria: Allergan, Merz, Galderma, P&G, Lumenis, Alastin, SkinFix; Speaker's Bureau: Galderma, Merz

Steven Dayan, MD
Consultant, Grant/Research Support, and Honoraria: Allergan, Galderma, Merz

James Q. Del Rosso, DO
Consultant: Aclaris, Allergan, Athenex, Bayer, Cutanea, Dermira, Galderma, Genentech, LeoPharma, Menlo, Novan, Ortho, Pfizer, Promius, Regeneron, SunPharma; Grant/Research Support: Aclaris, Allergan, Athenex, Bayer, Celgene, Cutanea, Dermira, Galderma, Genentech, LeoPharma, Menlo, Novan, Ortho, Promius, Regeneron, SunPharma; Honoraria & Speaker's Bureau: Aclaris, Allergan, Bayer, Celgene, Galderma, Genentech, LeoPharma, Novartis, Ortho, Pfizer, Promius, Regeneron, SunPharma; Other: Pharmaceutical Rep (Novartis) Respiratory Division (employee)

Lawrence F. Eichenfield, MD
Consultant/Honoraria: Allergan, Anacor/Pfizer, Cutanea, Dr Reddy's, DS Biopharma, Galderma Labs, Genetech, Leo Pharma, Lilly, Medimetriks, Ralaxar, Regeneron/Sanofi; Investigator: Galderma Labs, Leo Pharma, Regeneron/Sanofi; Consultant/Equity-Options: TopMD; Consultant, Advisory Board, Speaker/Honoraria

Julius W. Few, MD
Consultant & Honoraria: Sinclair Pharma, Venus Concepts, Zeltiq Aesthetics

Michael H. Gold, MD
Consultant & Advisory Boards: Aerolase, Allergan, Alma Lasers, Almirall, Anacor Pharmaceuticals, Aquavit Pharm, Bayer Health Care, Celgene, Clarisonic, SkinCeuticals, L'Oreal, Croma, DefanAge, DUSA Pharmaceuticals/Sun Pharma, EndyMed, Erchonia, Exeltis, Galderma, Intra Derm, Invasix, Johnson & Johnson, Lumenis, Merz, Neothetics, Novartis, Pierre Fabre, Prollenium, Promius, Sente, Sinclair Pharma, Smith & Nephew, Syneron-Candela, Suneva, Thermi Aesthetics, Valeant, Viviscal, Zimmer

David J. Goldberg, MD, JD
Consultant: Sensus, Amirall, RSI, WonTech, Strat Pharma; Grant/Research Support: Cutera, Cynosure, Stratpharma, Galderma, Merz, Allergan; Honoraria: Cutera, Sensus, WonTech, Lumenis, Merz; Stock Shareholder: Advent Pharma

Mercedes E. Gonzalez, MD
Honoraria & Speaker's Bureau: Pierre Fabre, Pfizer, Encore Dermatology

Andrew Heyman, MD
Nothing to Disclose

Bruce E. Katz, MD
Consultant: BTL; Grant/Research Support: Cynosure, Allergan; Honoraria: Merz, Galderma; Speaker's Bureau: Alma

Mark D. Kaufmann, MD
Stock Options for Modernizing Medicine, Inc.

Jonette E. Keri, MD, PhD
Consultant: Hoffman, LaRoche

Leon Kircik, MD
Abbott Laboratories: Speaker/Honoraria; Aclaris: Advisory Board; Acambis: Investigator; Allergan: Investigator, Advisory Board, Speaker, Consultant; Almirall: Consultant, Advisory Board; Amgen: Consultant, Investigator, Speaker; Anacor Pharmaceuticals: Investigator, Consultant, Advisory Board; Assos Pharma: Apeaker; Astellas Pharma: Investigator, Speaker; Asubio: Investigator; Berlex Laboratories (Bayer HealthCare Pharmaceuticals): Investigator; Biogen-Idec: Advisory Board; Biolife: Investigator; Biopelle: Investigator; Boehringer-Ingleheim: Investigator; Breckinridge Pharma: Investigator: Colbar: Consultant, Advisory Board; Celgene: Investigator, Advisory Board; Celgene: Investigator, Advisory Board; Centocor, Inc.: Investigator; Cellceutix: Investigator; Cipher: Consultant, Spaker, Advisory Board; Coherus: Investigator; CollaGenex: Investigator, Consultant, Speaker; Combinatrix: Investigator; Connetics Corporation: Investigator, Consultant, Speaker; Coria: Investigator; Dermavant: Investigator; Dermira: Investigator; Dermik Laboratories: Speaker; Dow Pharmacutical Sciences, Inc.: Investigator; Dusa: Investigator; Embil Pharmaceuticals: Speaker; Eli Lilly: Investigator; EOS: Advisory Board; Exeltis: Advisory Board, Consultant, Speaker, Investigator; Ferndale Laboratories: Advisory Board, Investigator; Galderma: Consultant, Speaker, Advisory Board, Investigator; Genentech: Advisory Board, Speaker, Investigator, Consultant; GlaxoSmithKline: Investigator; Health Point, LTD: Investigator; Idera: Investigator: Intendis: Advisory Board, Consultant, Investigator; Innocutis: Speaker, Advisory Board; Innovail; Speaker; Isdin: Advisory Board, Consultant; Johnson & Johnson: Consultant, Investigator, Advisory Board, Speaker, Stockholder; Laboratory Skin Care Inc.: Consultant; Leo: Investigator, Consultant, Speaker; L'Oreal: Investigator, Speaker; 3M: Speaker Investigator; maruho: Investigator; Medical International Technologies: Consultant; Merck: Consultant, Investigator; Medicis Pharmaceutical Corp.: Investigator; Merz: Consultant; Nano Bio: Advisory Board, Investigator; Noven Pharmaceuticals: Investigator; Nucryst Pharmaceuticals Corp: Investigator; Obagi: Investigator; Onset: Investigator, Speaker; OrthoNeutrogena: Speaker, Investigator, Advisory Board, Consultant; Promius: Investigator, Consultant, Advisory Board; PediaPharma: Speaker; QLT, Inc.: Investigator; PharmaDerm: Investigator, Speaker; Pfizer: Investigator; PuraCap: Consultant; Quinnova: Investigator, Advisory Board; Quatrix: Investigator; Serono (Merck Serono International SA): Speaker; SkinMedica, Inc.: Consultant, Investigator, Advisory Board, Speaker; Stiefel Laboratories, Inc.: Speaker, Investigator, Advisory Board, Consultant; Sun Pharma: Consultant, Advisory Board, Speaker, Investigator; Taro: Consultant/Speaker; TolerRx: Investigator; Triax: Speaker; UCB: Investigator, Consultant, Speaker; Valeant Pharmaceuticals Intl: Advisory Board, Investigator, Consultant; Valeant Pharmaceuticals Intl: Speaker; Warner-Chilcott: Advisory Board, Speaker, Investigator; XenoPort: Investigator; ZAGE: Consultant

Robert Kirsner, MD
Nothing to Disclose

Mark G. Lebwohl, MD
Research/Grant Support: Abbvie, Boehringer Ingelheim, Celgene, Eli Lilly, Incyte, Janssen/Johnson & Johnson, Leo Pharmaceuticals, Medimmune/Astra Zeneca, Novartis, Pfizer, Sciderm, Valeant, ViDac. Consultant: Allergan, Aqua, Dr. Reddy's Laboratories

Henry W. Lim, MD
Grant/Research Support (to the institution): Estee Lauder, Ferndale, Allergan, Incyte

Z. Paul Lorenc, MD, FACS
Consultant: Merz, Allergan, Galderma, Sinclair

Stephen H. Mandy, MD
Consultant: Proctor & Gamble, Almirall Pharma; Speaker's Bureau: Sinclair Pharma

Gary D. Monheit, MD
Consultant: Allergan, Revance, Galderma, Merz, Suneva; Grant/Research Support: Galderma, Teoxane, Allergan, Suneva, CROMA, Alphaeon, Sienna Pharmaceuticals

Mark S. Nestor, MD, PhD
Aclaris: Advisory Board/Honoraria; Actavis: Investigator/Grants; Aerolase: Advisory Board/Honoraria; Allergan: Investigator/Grants; Almirall: Advisory Board, Consultant/Honoraria; Annacor Pharmaceuticals: Investigator/Grants; Avita: Advisory Board/Honoraria; Bayer Healthcare: Advisory Board, Consultant/Honoraria; Brickell Biotech: Investigator/Grant; Castle Biosciences: Advisory Board/Honoraria; Cosmederm Biosciences: Investigator/Grant; CROMA Pharma GmbH: Investigator, Consultant/Grants/Honoraria; Cynova Laboratories: Investigator/Grant; DUSA Pharmaceuticals: Investigator/Grant; Demira: Investigator/Grant; Erchonia Corporation: Advisory Board/Honoraria; Evolus, Inc.: Investigator/Grants; Exeltis USA Dermatology: Investigator/Grants; Ferndale Laboratories: Advisory Board, Consultant, Investigator/Honoraria/Grants; Galderma Laboratories: Consultant, Investigator/Honoraria/Grants; IFC, S.A.: Investigator, Speaker/Grants/Honoraria; IntraDerm: Advisory Board/Honoraria; Johnson & Johnson: Advisory Board, Investigator, Consultant/Honoraria/Grants; La Lumiere, LLC: Advisory Board, Investigator, Consultant/Honoraria/Grants; LEO Pharma: Advisory Board, Investigator/Honoraria/Grants; Sensus Healthcare: Advisory Board, Consultant/Honoraria; Sinclair Pharma: Advisory Board, Investigator, Consultant/Honoraria/Grants; SkinFix: Advisory Board/Honoraria; Smith & Nephew: Advisory Board/Honoraria; Stratapharma: Advisory Board/Honoraria; Strathspey Crown: Stockholder; Thermi: Advisory Board, Speaker, Consultant/Honoraria

Michael L. Nestor, ISD
Nothing to Disclose

Anna Nichols, MD, PhD
Nothing to Disclose

Gabriel Nistor, MD
Stock Shareholder: AIVITA Biomedical, Inc.

Margaret C. Oliviero, MSN, ARNP-C
Consultant: 3 Gen, DermaSensor, Caliber ID, Heine, Canfield, FotoFinder

David M. Pariser, MD
Consultant/Honoraria: Bickel Biotechnology, Biofrontera AG, Celgene Corporation, Dermira, DUSA Pharmacuticals, Inc. LEO Pharma, US, Novartis Pharmaceuticals Corp., Pfizer Inc., Promius Pharmaceuticals, Regeneron, Sanofi, TheraVida, Valeant Pharmacuticals International; Principal Investigator/Grants/Research Funding: LEO Pharma, US, Abbott Laboratories, Amgen, Bickel Biotechnology, Celgene Corporation, Dermavant Sciences, Eli Lilly and Company, LEO Pharma, US, Merck & Co., Inc., Novartis Pharmaceuticals Corp., Novo Nordisk A/S, Ortho Dermatologics, Peplin Inc., Pfizer Inc., Photocure ASA, Promius Pharmaceuticals, Regeneron, Stiefel a GSK company, Valeant Pharmaceuticals International; Advisory Board/Honoraria: Pfizer, Inc.

Jason N. Pozner, MD
Consultant: Cytrellis; Honoraria: Sciton, Lutronic, InMode; Speaker's Bureau: Sciton, InMode, Lutronic, Jeisys, Cynosure; Stock Shareholder: Sciton, Cytrellis, Revance, Therapeutics MD, RealSelf

Harold S. Rabinovitz, MD
Consultant: 3 Gen,Canfield, Caliber ID, FotoFinder, MoleScope, DermaSensor

Darrell S. Rigel, MD
Consultant: Aclaris Therapeutics, Inc.; Advisory Board: Beirsdorf, Inc., LEO Pharma US, Novartis, Pierre Fabre, Valeant; Principal Investigator: Johnson & Johnson, Neutrogena; Board of Directors: Foamix

Theodore Rosen, MD
Nothing to Disclose

Frank Rosengaus, MD
Nothing to Disclose

William I. Roth, MD
Consultant, Honoraria: Sensus Healthcare

Neil S. Sadick, MD
Almirall: Consultant, Honoraria; Galderma USA: Consultant, Fees; Slender Medical Ltd.: Advisory Board, Stock Options; Vascular Insights, LLC: Stockholder, Stock Options; Venus Concept: Consultant, Stock Options; Actavis: Principal Investigator, Grant/Research Funding; Allergan, Inc.: Consultant, Honoraria; Anacor Pharmaceuticals: Principal Investigator, Grants/Research Funding; Auxilium Pharmaceuticals, Inc.: Consultant, Honoraria; Bayer: Principal Investigator, Grants/Research Funding; Biorasi, LLC: Principal Investigator, Grants/Research Funding; BTG PLC: Consultant, Honoraria; Carma Laboratories, Inc.: Other, Honoraria; Cassiopea SpA: Principal Investigator, Grants/Research Funding; Celgene Corporation: Speaker, Honoraria, Principal Investigator, Grants/Research; Cutera, Inc.: Speaker, Honoraria; Cynosure, Inc.: Principal Investigator, Grants/Research, Consultant, Honoraria; DUSA Pharmaceuticals, Inc.: Principal Investigator, Grants/Research Funding; Eclipse Medical: Honoraria; Eli Lilly and Company: Principal Investigator, Grants/Research Funding; Endo International plc: Principal Investigator, Grants/Research Funding, Consultant, Honoraria; EndyMed Medical Inc.: Speaker, Honoraria; Eternogen: Consultant, Stock Options; Ferndale Laboratories, Inc.: Consultant, Honoraria; Galderma Laboratories, LP: Advisory Board, Honoraria; Galderma USA: Principal Investigator, Grants/Research Funding; Gerson Lehrman Group: Consultant, Honoraria; Hydropeptide, Inc.: Principal Investigator, Grants/Research Support; Merz Aesthetics: Advisory Board, Honoraria, Consultant; Neostrata: Principal INvestigator, Grant/Research Funding; Novartis: Principal Investigator, Grant/Research Funding; Nutraceutical Wellness, LLC: Principal Investigator, Grants/Research Support; Palomar Medical Technologies: Principal Investigaor, Grants/Research Funding; Prescriber's Choice: Honoraria; Regeneron: Principal Investigator, Grants/Research Funding; Roche Laboratories: Principal Investigator, Grants/Research Funding; Samumed, LLC: Principal Investigator, Grants/Research Funding; Solta Medical: Speaker, Honoraria; Storz Medical AG: Speaker, Honoraria; Suneva Medical Inc.: Advisory Board, Consultant, Honoraria; Valeant Pharmaceuticals International: Consultant, Principal Investigator, Grant/Research Funding, Honoraria; Vanda Pharmaceuticals Inc.: Principal Investigator, Grant/Research Funding; Venus Concept: Speaker, Honoraria

Julie Santos, PA-C
Nothing to Disclose

Lawrence A. Schachner, MD
Investigator: Astellas, Ferndale Labs, Novartis, Organogenesis, Inc., Stiefel Laboratories, Berg labs, Sciton, Medimetriks; Consultant: Beiersdorf, Lexington, TopMD, Medimetriks, Brickell

Sahar Swidan, PharmD, BCPS
Honoraria: A4M, Amgen; Speaker's Bureau: A4M, Amgen

Darlene Tomlinson, MBA, MHL
Nothing to disclose

Antonella Tosti, MD
Consultant: P&G, DS Laboratories; Other/Royalty: Springer Verlag, CRC Press, Karger

David L. Wagener, MBA, CPA
Stock Shareholder: Advanced Dermatology Management, Inc.; CEO: Skin & Cancer Associates

Susan H. Weinkle, MD
Consultant: Allergan/Galderma; Grant/Research Support: Revance, Alphaeon, Teoxane; Honoraria: Revance/Sinclair; Speaker’s Bureau: Sinclair; Stock Shareholder: Dermvance

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ashley Marostica, RN, MSN
Nothing to disclose

Lindsay Borvansky
Nothing to disclose

Andrea Funk
Nothing to disclose

Liddy Knight
Nothing to disclose

Tiffany Blake Robins
Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and our Partner do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.